Glutathione

Biosynthesis and occurrence

Glutathione biosynthesis involves two adenosine triphosphate-dependent steps:

• First, γ-glutamylcysteine is synthesized from L-glutamate and L-cysteine. This conversion requires the enzyme glutamate–cysteine ligase (GCL, glutamate-cysteine synthase). This reaction is the rate-limiting step in glutathione synthesis.
• Second, glycine is added to the C-terminal of γ-glutamylcysteine. This condensation is catalyzed by glutathione synthetase.

While all animal cells are capable of synthesizing glutathione, synthesis in the liver is essential. GCLC knockout mice die within a month of birth due to the absence of hepatic GSH synthesis.

The unusual gamma amide linkage in glutathione protects it from hydrolysis by peptidases.

Occurrence

Glutathione is the most abundant non-protein thiol (-containing compound) in animal cells, ranging from 0.5 to 10 mmol/L. It is present in the cytosol and the organelles. In healthy cells and tissue, more than 90% of the total glutathione pool is in the reduced form (GSH), with the remainder in the disulfide form (GSSG). The cytosol holds 80-85% of cellular GSH and the mitochondria hold 10-15%.

Human beings synthesize glutathione, but a few eukaryotes do not, including some members of Fabaceae, Entamoeba, and Giardia. The only known archaea that make glutathione are halobacteria. Some bacteria, such as "Cyanobacteria" and Pseudomonadota, can biosynthesize glutathione.

Systemic availability of orally consumed glutathione is poor. It has low bioavailability because the tripeptide is the substrate of proteases (peptidases) of the alimentary canal, and due to the absence of a specific carrier of glutathione at the level of the cell membrane. The administration of N-acetylcysteine (NAC), a cysteine prodrug, helps replenish intracellular GSH levels.

Biochemical function

Glutathione exists in reduced (GSH) and oxidized (GSSG) states. The ratio of reduced glutathione to oxidized glutathione within cells is a measure of cellular oxidative stress where increased GSSG-to-GSH ratio is indicative of greater oxidative stress.

In the reduced state, the thiol group of cysteinyl residue is a source of one reducing equivalent. Glutathione disulfide (GSSG) is thereby generated. The oxidized state is converted to the reduced state by NADPH. This conversion is catalyzed by glutathione reductase: :NADPH + GSSG + H2O → 2 GSH + NADP+ + OH−

Roles

Antioxidant

GSH protects cells by neutralising (reducing) reactive oxygen species. This conversion is illustrated by the reduction of peroxides: :2 GSH + R2O2 → GSSG + 2 ROH (R = H, alkyl) and with free radicals: :GSH + R• → GSSG + RH

Regulation

Aside from deactivating radicals and reactive oxidants, glutathione participates in thiol protection and redox regulation of cellular thiol proteins under oxidative stress by protein S-glutathionylation, a redox-regulated post-translational thiol modification. The general reaction involves formation of an unsymmetrical disulfide from the protectable protein (RSH) and GSH: :RSH + GSH + [O] → GSSR + H2O

Glutathione is also employed for the detoxification of methylglyoxal and formaldehyde, toxic metabolites produced under oxidative stress. This detoxification reaction is carried out by the glyoxalase system. Glyoxalase I (EC 4.4.1.5) catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-lactoylglutathione. Glyoxalase II (EC 3.1.2.6) catalyzes the hydrolysis of S-D-lactoylglutathione to glutathione and D-lactic acid.

It maintains exogenous antioxidants such as vitamins C and E in their reduced (active) states.

Metabolism

Among the many metabolic processes in which it participates, glutathione is required for the biosynthesis of leukotrienes and prostaglandins. It plays a role in the storage of cysteine. Glutathione enhances the function of citrulline as part of the nitric oxide cycle. It is a cofactor and acts on glutathione peroxidase. Glutathione is used to produce S-sulfanylglutathione, which is part of hydrogen sulfide metabolism.

Conjugation

Glutathione facilitates metabolism of xenobiotics. Glutathione S-transferase enzymes catalyze its conjugation to lipophilic xenobiotics, facilitating their excretion or further metabolism. The conjugation process is illustrated by the metabolism of N-acetyl-p-benzoquinone imine (NAPQI). NAPQI is a reactive metabolite formed by the action of cytochrome P450 on paracetamol (acetaminophen). Glutathione conjugates to NAPQI, and the resulting ensemble is excreted. As a result of this reaction, cellular glutathione concentration tends to be depleted in the presence of acetaminophen.

In plants

In plants, glutathione is involved in stress management. It is a component of the glutathione-ascorbate cycle, a system that reduces poisonous hydrogen peroxide. It is the precursor of phytochelatins, glutathione oligomers that chelate heavy metals such as cadmium. Glutathione is required for efficient defence against plant pathogens such as Pseudomonas syringae and Phytophthora brassicae. Adenylyl-sulfate reductase, an enzyme of the sulfur assimilation pathway, uses glutathione as an electron donor. Other enzymes using glutathione as a substrate are glutaredoxins. These small oxidoreductases are involved in flower development, salicylic acid, and plant defence signalling.

In degradation of drug delivery systems

Among various types of cancer, lung cancer, larynx cancer, mouth cancer, and breast cancer exhibit higher concentrations (10-40 mM) of GSH compared to healthy cells. Thus, drug delivery systems containing disulfide bonds, typically cross-linked micro-nanogels, stand out for their ability to degrade in the presence of high concentrations of glutathione (GSH). This degradation process releases the drug payload specifically into cancerous or tumorous tissue, leveraging the significant difference in redox potential between the oxidizing extracellular environment and the reducing intracellular cytosol.

When internalized by endocytosis, nanogels encounter high concentrations of GSH inside the cancer cell. GSH, a potent reducing agent, donates electrons to disulfide bonds in the nanogels, initiating a thiol-disulfide exchange reaction. This reaction breaks the disulfide bonds, converting them into two thiol groups, and facilitates targeted drug release where it is needed most. This reaction is called a thiol-disulfide exchange reaction. :::::::::::R−S−S−R′+ 2GSH → R−SH + R′−SH + GSSG where R and *R''' are parts of the micro-nanogel structure, and *GSSG'' is oxidized glutathione (glutathione disulfide).

The breaking of disulfide bonds causes the nanogel to degrade into smaller fragments. This degradation process leads to the release of encapsulated drugs. The released drug molecules can then exert their therapeutic effects, such as inducing apoptosis in cancer cells.

Uses

Winemaking

The content of glutathione in must, the first raw form of wine, determines the browning, or caramelizing effect, during the production of white wine by trapping the caffeoyltartaric acid quinones generated by enzymic oxidation as grape reaction product. Its concentration in wine can be determined by UPLC-MRM mass spectrometry.

References

References

1. (2016). "CRC Handbook of Chemistry and Physics". [[CRC Press]].
2. (October 2003). "The changing faces of glutathione, a cellular protagonist". Biochemical Pharmacology.
3. (July 2003). "Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity". Analytical Biochemistry.
4. (May 2007). "Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure". Hepatology.
5. (1999). "Glutathione and its role in cellular functions". Free Radical Biology & Medicine.
6. (May 2023). "How to Increase Cellular Glutathione". Antioxidants.
7. (1967). "The measurement of glutathione in human epidermis using glutathione reductase". The Journal of Investigative Dermatology.
8. (29 April 2002). "Lateral gene transfer and parallel evolution in the history of glutathione biosynthesis genes". Genome Biology.
9. (2001). "Significance of glutathione in plant adaptation to the environment". Springer.
10. (1992). "The systemic availability of oral glutathione". European Journal of Clinical Pharmacology.
11. "Acetylcysteine Monograph for Professionals".
12. (2007). "N-acetylcysteine — a safe antidote for cysteine/glutathione deficiency". Current Opinion in Pharmacology.
13. (January 2022). "Glutathione in Brain Disorders and Aging". Molecules.
14. (August 2001). "Determination of blood total, reduced, and oxidized glutathione in pediatric subjects". Clinical Chemistry.
15. Lu SC. (May 2013). "Glutathione synthesis". Biochimica et Biophysica Acta (BBA) - General Subjects.
16. (June 2013). "Partition and turnover of glutathione reductase from Saccharomyces cerevisiae: a proteomic approach". Journal of Proteome Research.
17. Michael Brownlee. (2005). "The pathobiology of diabetic complications: A unifying mechanism". Diabetes.
18. Guoyao Wu. (2004). "Glutathione Metabolism and its Implications for Health". Journal of Nutrition.
19. Dalle-Donne, Isabella. (2009). "Protein ''S''-glutathionylation: a regulatory device from bacteria to humans". Trends in Biochemical Sciences.
20. (December 2000). "Metabolism and functions of glutathione in brain". Progress in Neurobiology.
21. (1989). "Mechanism of interaction of vitamin E and glutathione in the protection against membrane lipid peroxidation". Annals of the New York Academy of Sciences.
22. (1964). "Reduction of dehydroascorbic acid by animal tissues". Nature.
23. (June 1999). "Phytochelatin synthase genes from Arabidopsis and the yeast ''Schizosaccharomyces pombe''". The Plant Cell.
24. (2001). "Role of the glutathione/glutaredoxin and thioredoxin systems in yeast growth and response to stress conditions". Molecular Microbiology.
25. (22 July 2014). "Biosynthesis of a central intermediate in hydrogen sulfide metabolism by a novel human sulfurtransferase and its yeast ortholog.". Biochemistry.
26. Hayes, John D.. (2005). "Glutathione transferases". Annual Review of Pharmacology and Toxicology.
27. (June 1998). "Ascorbate and Glutathione: Keeping Active Oxygen Under Control". Annual Review of Plant Physiology and Plant Molecular Biology.
28. (June 1999). "Phytochelatin synthase genes from Arabidopsis and the yeast Schizosaccharomyces pombe". The Plant Cell.
29. (January 2007). "Identification of PAD2 as a gamma-glutamylcysteine synthetase highlights the importance of glutathione in disease resistance of Arabidopsis". The Plant Journal.
30. (2008). "The role of glutathione in photosynthetic organisms: emerging functions for glutaredoxins and glutathionylation". Annual Review of Plant Biology.
31. (December 2012). "Glutathione levels in human tumors". Biomarkers.
32. (September 2018). "Nano based drug delivery systems: recent developments and future prospects". J Nanobiotechnology.
33. (August 2015). "Biodegradable Polymer Nanogels for Drug/Nucleic Acid Delivery". Chem Rev.
34. (2014). "Glutathione-Sensitive Nanogels for Drug Release". Chemical Engineering Transactions.
35. Gilbert, H.F.. (1990). "Advances in Enzymology and Related Areas of Molecular Biology".
36. Gilbert, H.F.. (1995). "Biothiols, Part A: Monothiols and Dithiols, Protein Thiols, and Thiyl Radicals".
37. (January 2019). "Degradable redox-responsive disulfide-based nanogel drug carriers via dithiol oxidation polymerization". Biomater Sci.
38. (1991). "Influence of must composition on phenolic oxidation kinetics". Journal of the Science of Food and Agriculture.
39. (January 2015). "Straightforward method to quantify GSH, GSSG, GRP, and hydroxycinnamic acids in wines by UPLC-MRM-MS". Journal of Agricultural and Food Chemistry.